Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

Prolactin slows down hair growth in mice.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Alopecia patients have less GPER-1, which might affect hair loss.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Both genetic and lifestyle factors significantly affect female hair loss.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Scalp hair sweating is a significant predictor of hair cortisol levels.